ARCHIVES

Senate Committee Approves $1.74 Billion for NCI, Seeks Activation of Dietary Intervention Trial

This article is from The Cancer Letter archive.

Vol. 16 No. 40 | October 19, 1990

Download PDF Visit The Full Archive

Related Articles

Center Core Grants Picture Less Bleak; Competing Renewals To Receive 50% Of Recommended Increases

January 4, 1980

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

In Brief: Administration “Streamlining” Accomplished; DCCR contract Merit Review In Open Session

February 24, 1978

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Five Advocates Named To SWOG Committees; NCI, NASA Sign Nanotechnology Agreement.

April 21, 2000